DP World Foundation has donated Dh15 million to Al Jalila Foundation to support the development of the Hamdan bin Rashid Cancer Hospital, highlighting its commitment to corporate social responsibility and community welfare.
The contribution is part of DP World Foundation's broader efforts to support vital healthcare services and improve access to quality healthcare for cancer patients.
The allocated funds will support the development of Dubai's first integrated cancer hospital, scheduled to open in 2026. The advanced healthcare facility, which is being established in collaboration with the Al Jalila Foundation, will feature 50 clinics, 30 research areas, 60 infusion rooms, and 116 inpatient beds spread across a sprawling 56,000-square-metre campus.
His Excellency Nasser Abdulla Al Neyadi, Chief Officer Group Security, Government Relations & Public Affairs (GRPA), and DP World Foundation, presented the contribution during a visit to the Al Jalila Foundation, including the Mohammed Bin Rashid Biomedical Research Centre, where he met with key healthcare officials and stakeholders.
HE Al Neyadi said: "We are deeply committed to making a real difference in society, and this donation reflects our dedication to supporting healthcare institutions and ensuring that quality care is accessible to everyone. We are proud to contribute to such a respected institution leading the way in cancer care and research. Together, we aspire to foster a healthier future for all."
Dr. Amer Al Zarooni, CEO of the Al Jalila Foundation, said: "We extend heartfelt gratitude to the DP World Foundation for their generous donation towards the Hamdan Bin Rashid Cancer Hospital. The collaboration exemplifies the transformative impact of partnerships in accelerating the delivery of critical healthcare services and further emphasizes Dubai Health's commitment to improving the health and well-being of our community.
Together, with the support of our partners, we are steadfast in our dedication to transforming lives and ensuring better health for everyone."
The philanthropic arm of DP World, DP World Foundation, is committed to promoting social responsibility and supporting those in need, regardless of nationality, race, or religion. Earlier this year, DP World Foundation contributed Dh 10 million to the Mothers' Endowment Campaign launched to support the education of millions around the world.

The Academic Guidance for Physicians Program helped applicants meet the requirements to enroll in medical residency programs in Canada and the US.

Dubai Health, the first integrated academic health system in Dubai has announced that 100% of its Emirati scholars from the Graduate Medical Education at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) have successfully secured training opportunities for medical residency programs in Canada and the US. This notable achievement was facilitated by the Academic Mentorship Program for Physicians, a flagship initiative under the Deanship of Graduate Medical Education at MBRU designed to support trainees in pursuing medical residency training programs in North America.

Professor Alawi Alsheikh-Ali, Deputy CEO and Chief Academic Officer of Dubai Health, and Provost of MBRU, said: “This is a very special moment for Dubai Health, celebrating the success of our young scholars who are pushing the envelope and getting outside of their comfort zones to pursue their graduate medical education abroad, which is a testament to the caliber of medical education, mentorship, and clinical training that is distinctively offered at MBRU, the University within Dubai's first integrated academic health system. This success not only reflects the individual achievements of our young doctors but also underscores Dubai Health's commitment to empowering local medical talent, ensuring that they receive opportunities to excel on the global stage. I'm very proud of these young doctors and very proud of the graduate medical education team that is supporting them.”

Professor Sulaiman AlEmran, Dean of Graduate Medical Education at MBRU, said: “We are honored by the accomplishments of our Emirati scholars and MBRU’s new Academic Mentorship Program for Physicians. These achievements reflect MBRU’s commitment to supporting trainees in their learning journey, aligning with Dubai Health’s goal to cultivate local medical talent in various medical fields,”

“The Deanship of Graduate Medical Education at MBRU implemented a standardized program for academic mentorship, offering comprehensive support to medical trainees aspiring to enroll in medical residency programs in Canada and the US. The initiative included meticulous review and optimization of trainees' academic performances and resumes, coupled with informative workshops addressing application requirements and refining personal interview skills. The program facilitated communication between trainees and prominent Canadian and American institutions, introducing them to Dubai Health, and provided diligent follow-up throughout all application stages and requirements,” he added.

A total of 11 trainees who participated in the academic mentorship program, successfully meeting all admission requirements and criteria for prestigious Canadian and American institutions, including the successful completion of medical licensing exams. The Deanship of Graduate Medical Education oversaw the review process of all documents, submitting them to numerous universities in Canada and the US in collaboration with UAE attachés.

Each applicant excelled in meeting the admission requirements, including personal interviews. Successful candidates have been accepted into several medical residency programs, such as internal medicine, emergency medicine, neurology, ophthalmology, orthopedic surgery, and diagnostic radiology. Notable institutions welcoming MBRU trainees include the University of Texas in the US, as well as Canadian universities such as McGill University, the University of British Columbia, the University of Alberta, the University of Toronto, McMaster University, and Queen's University.

This unprecedented accomplishment of securing 11 training opportunities across Canadian and American institutions is a pinnacle achievement in the UAE's healthcare landscape. Moreover, this success aligns seamlessly with Dubai Health's commitment to investing in developing national healthcare talents, fostering excellence in healthcare services, and championing learning and discovery to impact lives.

Dubai Health showcased its latest advancements in healthcare technology and innovation at GITEX, the biggest tech and startup show in the world. This year’s event theme centers on the integration of artificial intelligence (AI) across various sectors, with a particular focus on AI in health.

Teaming up with the Dubai Digital pavilion, Dubai Health is offering visitors a 20-minute journey that showcases how the integrated academic health system’s latest technological solutions are enhancing patient care and operational efficiency.

One of the key highlights of Dubai Health’s exhibit is the use of virtual reality (VR) technology at its Thalassemia Center, a solution currently being studied by Dubai Health’s Innovation and Digital Health team. This study aims to alleviate anxiety and pain during cannulation procedures. Patients wear VR headsets, immersing them in a therapeutic 3D environment designed to enhance comfort and overall experience during the procedure. This innovative, first-of-its-kind approach has the potential to transform the experience for patients, aligning with Dubai Health’s objective to elevate the standard of care and its vision to advance health for humanity.

In addition, Dubai Health’s Innovation and Digital Health team is also conducting a validation study on wearable ambulatory blood pressure monitoring technology using a smartwatch. The study evaluates the accuracy and effectiveness of this technology in delivering continuous blood pressure measurements, presenting a more convenient alternative to traditional methods. These initiatives underscore Dubai Health's ongoing efforts to incorporate advanced technology into healthcare to improve patient outcomes and streamline healthcare delivery.

Another project on display is the Ambient Clinical Documentation Solution, a tool designed to enhance clinical documentation efficiency by leveraging Generative AI. This solution enables clinicians to verbally document patient encounters, significantly reducing the time required for documentation. This allows clinicians to spend more time and provide better experience to our patients. The voice notes are processed by an AI-driven system that generates specialty-specific clinical notes, which clinicians then review and sign.

Atif Al Braiki, Chief Digital and AI Officer at Dubai Health,  commented, “Our participation in GITEX 2024 underscores our commitment to leveraging cutting-edge technology to transform healthcare delivery. By integrating AI and other advanced technologies in our day-to-day care, we are proud to be showcasing how we are constantly adapting to enhance patient outcomes, streamline operations, and set new standards in healthcare innovation. In line with our commitment to healthcare excellence, integrating these technologies will help us to realize our vision of advancing health for humanity.”

Dubai Health’s presence at GITEX 2024, being held at the Dubai World Centre, is a testament to its dedication to remaining at the forefront of the technological healthcare revolution, harnessing innovations to put the patient first.

Building on Dubai Health's vision to advance health for humanity, The Royal Marsden NHS Foundation Trust has been selected to support the clinical and operational development of the Hamdan Bin Rashid Cancer Hospital (HBRCH), Dubai's first integrated, comprehensive cancer hospital.

The partnership marks a significant step forward in enhancing the standard of cancer treatment in Dubai, where specialized and compassionate care will be accessible in one place.

As one of the world's leading hospitals dedicated to cancer diagnosis, treatment, research, and education, The Royal Marsden will work with Dubai Health to establish a model of excellence in comprehensive cancer care at HBRCH. Their renowned expertise will be leveraged across several key areas, including developing specialist, evidence-based models of care, early diagnosis, and treatment pathways that guide patients through every step of their journey.

The HBRCH program of care will span from early detection to treatment, recovery, and post-treatment support. A key focus of this partnership will be building a world-class, specialized team of cancer care professionals. This will involve creating a robust workforce plan, developing advanced training programmers, and fostering a culture of continuous learning. Additionally, the partnership will seek to establish a cancer research program, fostering a culture of discovering transformative advancements in cancer care.

Her Excellency Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Member of Dubai Health Board of Directors, said, “We are honored to join forces with The Royal Marsden, a global leader in cancer research and treatment. Their renowned expertise and approach to care perfectly complement the care, learning, discovery, and giving missions of our integrated academic health system. Through this partnership, we are honoring the collective generosity of our esteemed donors whose unwavering support to Al Jalila Foundation is fulfilling our vision for the Hamdan Bin Rashid Cancer Hospital to become a beacon of hope for patients and families facing a cancer diagnosis. It propels us closer to achieving the Dubai Social Agenda 33 goal of delivering a world-class healthcare system of the highest efficiency and quality."

Dame Cally Palmer, Chief Executive, The Royal Marsden, said: “I am delighted that The Royal Marsden has been chosen to work in partnership with Dubai Health to advance the clinical development of the Hamdan Bin Rashid Cancer Hospital. This is an excellent opportunity for international collaboration, and to adapt the best practices in state-of-the-art healthcare provision and establish the structure upon which this advanced, innovative and future-looking hospital can be based.”

“At The Royal Marsden our integrated NHS and Private Care model, underpinned by a research and academic infrastructure, delivers outstanding personalized care for our patients. Through a staged program of work, The Royal Marsden and Dubai Health aim to establish a long-term strategic partnership that will not only develop a new hospital but support specialized cancer care across the wider healthcare system in Dubai,” she added.

Set to open in 2026, the HBRCH will offer a groundbreaking model of care under Dubai Health. As part of Dubai’s first integrated academic health system, the comprehensive cancer hospital will create multidisciplinary teams to spearhead a transformative shift in care delivery. Research and clinical trials will be at the heart of the hospital, fostering a culture of discovery and accelerating progress in cancer care. With 50 clinics, 30 research areas, 60 infusion rooms, and 116 inpatient beds spread across a sprawling 56,000-square-metre campus, the hospital is positioned to become a beacon of hope for cancer patients in the UAE and the region.